Cargando…

Higher susceptibility to 6 Hz corneal kindling and lower responsiveness to antiseizure drugs in mouse models of Alzheimer's disease

OBJECTIVE: Epileptic spikes and seizures seem present early in the disease process of Alzheimer's disease (AD). However, it is unclear how soluble and insoluble amyloid beta (Aβ) and tau proteins affect seizure development in vivo. We aim to contribute to this field by assessing the vulnerabili...

Descripción completa

Detalles Bibliográficos
Autores principales: Vande Vyver, Maxime, Barker‐Haliski, Melissa, Aourz, Najat, Nagels, Guy, Bjerke, Maria, Engelborghs, Sebastiaan, De Bundel, Dimitri, Smolders, Ilse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804582/
https://www.ncbi.nlm.nih.gov/pubmed/35775150
http://dx.doi.org/10.1111/epi.17355
_version_ 1784862143475089408
author Vande Vyver, Maxime
Barker‐Haliski, Melissa
Aourz, Najat
Nagels, Guy
Bjerke, Maria
Engelborghs, Sebastiaan
De Bundel, Dimitri
Smolders, Ilse
author_facet Vande Vyver, Maxime
Barker‐Haliski, Melissa
Aourz, Najat
Nagels, Guy
Bjerke, Maria
Engelborghs, Sebastiaan
De Bundel, Dimitri
Smolders, Ilse
author_sort Vande Vyver, Maxime
collection PubMed
description OBJECTIVE: Epileptic spikes and seizures seem present early in the disease process of Alzheimer's disease (AD). However, it is unclear how soluble and insoluble amyloid beta (Aβ) and tau proteins affect seizure development in vivo. We aim to contribute to this field by assessing the vulnerability to 6 Hz corneal kindling of young female mice from two well‐characterized transgenic AD models and by testing their responsiveness to selected antiseizure drugs (ASDs). METHODS: We used 7‐week‐old triple transgenic (3xTg) mice that have both amyloid and tau mutations, and amyloid precursor protein Swedish/presenillin 1 dE9 (APP/PS1) mice, bearing only amyloid‐related mutations. We assessed the absence of plaques via immunohistochemistry and analyzed the concentrations of both soluble and insoluble forms of Aβ(1–42) and total tau (t‐tau) in brain hippocampal and prefrontal cortical tissue. Seven‐week‐old mice of the different genotypes were subjected to the 6 Hz corneal kindling model. After kindling acquisition, we tested the anticonvulsant effects of three marketed ASDs (levetiracetam, brivaracetam, and lamotrigine) in fully kindled mice. RESULTS: No Aβ plaques were present in either genotype. Soluble Aβ(1–42) levels were increased in both AD genotypes, whereas insoluble Aβ(1–42) concentrations were only elevated in APP/PS1 mice compared with their respective controls. Soluble and insoluble forms of t‐tau were increased in 3xTg mice only. 3xTg and APP/PS1 mice displayed more severe seizures induced by 6 Hz corneal kindling from the first stimulation onward and were more rapidly kindled compared with control mice. In fully kindled AD mice, ASDs had less‐pronounced anticonvulsive effects compared with controls. SIGNIFICANCE: Mutations increasing Aβ only or both Aβ and tau in the brain enhance susceptibility for seizures and kindling in mice. The effect of ASDs on seizures measured by the Racine scale is less pronounced in both investigated AD models and suggests that seizures of young AD mice are more difficult to treat.
format Online
Article
Text
id pubmed-9804582
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-98045822023-01-03 Higher susceptibility to 6 Hz corneal kindling and lower responsiveness to antiseizure drugs in mouse models of Alzheimer's disease Vande Vyver, Maxime Barker‐Haliski, Melissa Aourz, Najat Nagels, Guy Bjerke, Maria Engelborghs, Sebastiaan De Bundel, Dimitri Smolders, Ilse Epilepsia Research Article OBJECTIVE: Epileptic spikes and seizures seem present early in the disease process of Alzheimer's disease (AD). However, it is unclear how soluble and insoluble amyloid beta (Aβ) and tau proteins affect seizure development in vivo. We aim to contribute to this field by assessing the vulnerability to 6 Hz corneal kindling of young female mice from two well‐characterized transgenic AD models and by testing their responsiveness to selected antiseizure drugs (ASDs). METHODS: We used 7‐week‐old triple transgenic (3xTg) mice that have both amyloid and tau mutations, and amyloid precursor protein Swedish/presenillin 1 dE9 (APP/PS1) mice, bearing only amyloid‐related mutations. We assessed the absence of plaques via immunohistochemistry and analyzed the concentrations of both soluble and insoluble forms of Aβ(1–42) and total tau (t‐tau) in brain hippocampal and prefrontal cortical tissue. Seven‐week‐old mice of the different genotypes were subjected to the 6 Hz corneal kindling model. After kindling acquisition, we tested the anticonvulsant effects of three marketed ASDs (levetiracetam, brivaracetam, and lamotrigine) in fully kindled mice. RESULTS: No Aβ plaques were present in either genotype. Soluble Aβ(1–42) levels were increased in both AD genotypes, whereas insoluble Aβ(1–42) concentrations were only elevated in APP/PS1 mice compared with their respective controls. Soluble and insoluble forms of t‐tau were increased in 3xTg mice only. 3xTg and APP/PS1 mice displayed more severe seizures induced by 6 Hz corneal kindling from the first stimulation onward and were more rapidly kindled compared with control mice. In fully kindled AD mice, ASDs had less‐pronounced anticonvulsive effects compared with controls. SIGNIFICANCE: Mutations increasing Aβ only or both Aβ and tau in the brain enhance susceptibility for seizures and kindling in mice. The effect of ASDs on seizures measured by the Racine scale is less pronounced in both investigated AD models and suggests that seizures of young AD mice are more difficult to treat. John Wiley and Sons Inc. 2022-08-02 2022-10 /pmc/articles/PMC9804582/ /pubmed/35775150 http://dx.doi.org/10.1111/epi.17355 Text en © 2022 The Authors. Epilepsia published by Wiley Periodicals LLC on behalf of International League Against Epilepsy. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Research Article
Vande Vyver, Maxime
Barker‐Haliski, Melissa
Aourz, Najat
Nagels, Guy
Bjerke, Maria
Engelborghs, Sebastiaan
De Bundel, Dimitri
Smolders, Ilse
Higher susceptibility to 6 Hz corneal kindling and lower responsiveness to antiseizure drugs in mouse models of Alzheimer's disease
title Higher susceptibility to 6 Hz corneal kindling and lower responsiveness to antiseizure drugs in mouse models of Alzheimer's disease
title_full Higher susceptibility to 6 Hz corneal kindling and lower responsiveness to antiseizure drugs in mouse models of Alzheimer's disease
title_fullStr Higher susceptibility to 6 Hz corneal kindling and lower responsiveness to antiseizure drugs in mouse models of Alzheimer's disease
title_full_unstemmed Higher susceptibility to 6 Hz corneal kindling and lower responsiveness to antiseizure drugs in mouse models of Alzheimer's disease
title_short Higher susceptibility to 6 Hz corneal kindling and lower responsiveness to antiseizure drugs in mouse models of Alzheimer's disease
title_sort higher susceptibility to 6 hz corneal kindling and lower responsiveness to antiseizure drugs in mouse models of alzheimer's disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804582/
https://www.ncbi.nlm.nih.gov/pubmed/35775150
http://dx.doi.org/10.1111/epi.17355
work_keys_str_mv AT vandevyvermaxime highersusceptibilityto6hzcornealkindlingandlowerresponsivenesstoantiseizuredrugsinmousemodelsofalzheimersdisease
AT barkerhaliskimelissa highersusceptibilityto6hzcornealkindlingandlowerresponsivenesstoantiseizuredrugsinmousemodelsofalzheimersdisease
AT aourznajat highersusceptibilityto6hzcornealkindlingandlowerresponsivenesstoantiseizuredrugsinmousemodelsofalzheimersdisease
AT nagelsguy highersusceptibilityto6hzcornealkindlingandlowerresponsivenesstoantiseizuredrugsinmousemodelsofalzheimersdisease
AT bjerkemaria highersusceptibilityto6hzcornealkindlingandlowerresponsivenesstoantiseizuredrugsinmousemodelsofalzheimersdisease
AT engelborghssebastiaan highersusceptibilityto6hzcornealkindlingandlowerresponsivenesstoantiseizuredrugsinmousemodelsofalzheimersdisease
AT debundeldimitri highersusceptibilityto6hzcornealkindlingandlowerresponsivenesstoantiseizuredrugsinmousemodelsofalzheimersdisease
AT smoldersilse highersusceptibilityto6hzcornealkindlingandlowerresponsivenesstoantiseizuredrugsinmousemodelsofalzheimersdisease